FDA Adverse Event
Injury
Summary report: N
BI300 IMPLANT 4 MM
MDR report key: 10446432
·
Received August 24, 2020
Report
- Report Number
- 6000034-2020-02186
- Event Type
- Injury
- Date Received
- August 24, 2020
- Date of Event
- August 4, 2020
- Report Date
- August 3, 2020
- Manufacturer
- COCHLEAR BONE ANCHORED SOLUTIONS AB
- Product Code
- LXB
- PMA / PMN Number
- K100360
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- OTHER
Narratives
Additional Manufacturer Narrative · 1
THIS REPORT IS SUBMITTED ON AUGUST 25, 2020.
Description of Event or Problem · 1
PER THE SURGEON, THE PATIENT EXPERIENCED SKIN OVERGROWTH ON THE ABUTMENT. TREATMENT WITH TOPICAL STEROIDS AND ANTIBIOTICS WERE UNSUCCESSFUL. SUBSEQUENTLY, THE PATIENT UNDERWENT A PROCEDURE TO REMOVE THE EXCESS SKIN ON (B)(6) 2020.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 905259 | BI300 IMPLANT 4 MM | COCHLEAR BAHA CONNECT SYSTEM | LXB | COCHLEAR BONE ANCHORED SOLUTIONS AB | 92129 | ASKU |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 21 YR | Required Intervention |